Fair point on BGFV. Maybe it's down today on the Russia vaccine. I have my doubts on the Russia one, but news of a successful vaccine is coming. So there could be a bigger selloff looming on the stay at home plays that have done so well in 2020. Could really wreak havoc on the Nasdaq.
At least BGFV earned .40+/share last year before the pandemic. And before the recent cost cutting measures. Plus they should be sitting on several dollars per share in cash with no debt by yearend.